EUVIMEDEUVIMED entdecken
Crossref

Nucleus delivery of doxorubicin by gadolinium-functionalized carbon dot drug delivery system for HCC imaging and therapy

Boyang Xue, Qiang Li, Yanjiao Xing, Hongkai Mu, Yongzhen Yang, Lin Chen, Shiping Yu, Rongrong Guo

Microchimica Acta · 2025

DOI: 10.1007/s00604-025-07474-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Boyang Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, …. Hauptthemen laut MEDLINE: Doxorubicin, Gadolinium, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Research Project of Health Commission of Shanxi Province, Research Project of Second Hospital of Shanxi Medical University, Shanxi Scholarship Council of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To overcome the dual challenges of suboptimal therapeutic outcomes and delayed detection in hepatocellular carcinoma (HCC), a nucleus-targeting theranostic nanoplatform based on gadolinium-functionalized carbon dots (GdCDs) is presented. GdCDs were synthesized via a one-step hydrothermal method utilizing neutral red and citric acid as carbon precursors and gadolinium chloride hexahydrate as the paramagnetic source, showing good fluorescence (FL) and magnetic resonance imaging (MRI) capabilities. After modified with a nuclear localization sequence (NLS), GdCDs were loaded with doxorubicin (DOX) to yield the integrated theranostic platform: Nucleus-targeting gadolinium-functionalized carbon dot drug delivery system (NT-GdCDs-DDS) for FL/MRI dual-modality imaging and nucleus-targeting drug delivery. NT-GdCDs-DDS exhibited optimal excitation/emission wavelengths at 497/596 nm, a high longitudinal relaxivity (r1) of 23.11 mM-1 s-1, and a DOX loading efficiency of 61.9%. Results of antitumor activity assays in vitro demonstrated the viability of HepG2 cells incubated with 400 μg/mL NT-GdCDs-DDS for 24 h was 8.12%, demonstrating strong antitumor activity. Furthermore, a significant tumor growth suppression in mice was observed by treated with NT-GdCDs-DDS over a 15-day period, showing superiority to free DOX. These findings establish NT-GdCDs-DDS as a potent theranostic nanoplatform for simultaneous HCC imaging and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinGadoliniumCarcinoma, HepatocellularLiver NeoplasmsQuantum DotsAntibiotics, AntineoplasticDrug Delivery SystemsDrug CarriersHumansCarbonAnimalsHep G2 CellsMiceMagnetic Resonance ImagingCell SurvivalMice, Inbred BALB CCell NucleusMice, Nude

Stichwörter der Autor:innen

Carbon dotsFluorescence imagingMagnetic resonance imagingNucleus-targetingTheranostics

Substanzen

DoxorubicinGadoliniumCarbonAntibiotics, AntineoplasticDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, PR China.
  • Interventional Therapy Department, Second Hospital of Shanxi Medical University, Taiyuan, 030001, PR China.
  • Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, PR China. yangyongzhen@tyut.edu.cn.
  • Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, PR China. chenlin01@tyut.edu.cn.
  • Interventional Therapy Department, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 0…
  • Ultrasound Department, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, PR Ch…

Förderung

  • Research Project of Health Commission of Shanxi Province
  • Research Project of Second Hospital of Shanxi Medical University
  • Shanxi Scholarship Council of China
  • Key International Science and Technology Cooperation Projects of Shanxi Province
  • Foundational Research Project of Shanxi Province
  • National Natural Science Foundation of China
  • Four "Batches" Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province
  • The Science and Education Cultivation Fund of the National Cancer and Regional Medical Center of Shanxi Provincial Cancer Hospital

Zitieren

APA

Xue, B., Li, Q., Xing, Y., Mu, H., Yang, Y., Chen, L., Yu, S., & Guo, R. (2025). Nucleus delivery of doxorubicin by gadolinium-functionalized carbon dot drug delivery system for HCC imaging and therapy. Microchimica Acta. https://doi.org/10.1007/s00604-025-07474-6

Vancouver

Xue B, Li Q, Xing Y, Mu H, Yang Y, Chen L, et al. Nucleus delivery of doxorubicin by gadolinium-functionalized carbon dot drug delivery system for HCC imaging and therapy. Microchimica Acta. 2025. doi:10.1007/s00604-025-07474-6

BibTeX
@article{Xue2025,
  author = {Xue, Boyang and Li, Qiang and Xing, Yanjiao and Mu, Hongkai and Yang, Yongzhen and Chen, Lin and Yu, Shiping and Guo, Rongrong},
  title = {Nucleus delivery of doxorubicin by gadolinium-functionalized carbon dot drug delivery system for HCC imaging and therapy},
  journal = {Microchimica Acta},
  year = {2025},
  doi = {10.1007/s00604-025-07474-6}
}
Kostenlos starten →